Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling.
Characterization of methamphetamine's (METH) dose-dependent effects on brain neurochemistry may represent a critical component for better understanding the range of resultant behavioral pathologies. Most human studies, however, have assessed only the effects of long term, high dose METH abuse (e.g., greater than 1000 mg/day) in individuals meeting DSM-IV criteria for METH dependence. Yet, for the majority of METH abusers, their patterns of METH exposure that consist of lower doses remain less well-characterized. In this study, blood samples were obtained from 105 individuals detained by police for possible criminal activity and testing positive for stimulants by EMIT assay. METH blood concentrations were subsequently quantified by GC-MS and were predominantly in the low micromolar range (0.1-11.1 microM), with median and mean values of 1.3 microM (0.19 mg/l) and 2 microM (0.3 mg/l), respectively. Pharmacokinetic calculations based on these measured values were used to estimate initial METH body burdens, the median value being 52 mg. Modeling a 52 mg dose for a 4 day-METH maintenance exposure pattern of 4 doses/day at 4 h intervals showed that blood concentrations remained between 1 and 4 microM during this period. Collectively, these data present evidence for a METH exposure pattern distinct from high dose-METH abuse and provide the rationale for assessing potential brain pathology associated with such lower dose-METH exposure.
Melega
William P
WP
Department of Molecular and Medical Pharmacology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. wmelega@mednet.ucla.edu
Cho
Arthur K
AK
Harvey
Dennis
D
Laćan
Goran
G
D000661:Amphetamine / Q000097:blood / Q000493:pharmacokinetics; D000697:Central Nervous System Stimulants / Q000097:blood* / Q000493:pharmacokinetics*; D004305:Dose-Response Relationship, Drug; D005554:Forensic Medicine; D006801:Humans; D008694:Methamphetamine / Q000097:blood* / Q000493:pharmacokinetics*; D019966:Substance-Related Disorders / Q000097:blood*; D013997:Time Factors
D000697:Central Nervous System Stimulants; D008694:Methamphetamine; D000661:Amphetamine